Researchers of the Melnick Lab, led by Prof. Ari Melnick, medicine, recently published a study identifying a key mutation that disrupts the B-cell natural selection process during immune response, ...

The MarketWatch News Department was not involved in the creation of this content. -- Kling-Select is a uniquely promising approach to identifying novel targets and therapeutic antibodies from human ...

The key to understanding how the most aggressive lymphomas arise and resist current therapies may lie in mutations that disrupt a critical natural selection process among antibody-producing B cells, ...

Researchers identified a key receptor that primes the formation of autoreactive B cells. Disrupting this pathway may be a potential therapy for lupus and beyond.

Researchers from Osaka University find that the tyrosine kinase Csk inhibits germinal center B cell signaling, thereby decreasing the production of reactive oxygen species and apoptosis, and promoting ...

Monoclonal B-cell lymphocytosis is when your body produces an elevated number of identical B cells. In some cases, it can develop into chronic lymphocytic leukemia. Monoclonal B-cell lymphocytosis ...